Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas

Endocrine Pathology

Volumn 16, Issue 1, 2005, Pages 53-62

  Donangelo, Ines ^a   Marcos, Heliomar Pereira ^a   Araújo, Paula Bruna ^a   Marcondes, Jorge ^a   Niemeyer Filho, Paulo ^b   Gadelha, Mônica ^a,c   Chimelli, Leila ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Neurosurgery Unit   (Brazil)

^c NONE   (Brazil)

Author keywords

Acromegaly; Pathogenesis; Pituitary adenoma; RB1 gene; Retinoblastoma protein

Indexed keywords

HUMAN GROWTH HORMONE; RETINOBLASTOMA PROTEIN;

ACROMEGALY; ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TUMOR CELL;

EID: 24644470534     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/ep:16:1:053     Document Type: Article

References (52)

1. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M. Rare mutation of the gs alpha-sub-unit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer introduced restriction analysis. Cancer 72:1386-1393, 1993.
2. Yang I, Park S, Ryu M, et al. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients. Eur J Endocrinol 134:720-726, 1996.
3. Lyons J, Landis CA, Harsh G, et al. Two G protein oncogenes in human endocrine tumors. Science 249:655-659, 1990.
4. Johnson MC, Codner E, Eggers M, Mosso L, Rodriguez JA, Cassoria F. Gsp mutations in Chilean patients harboring growth hormone secreting pituitary tumors. J Pediatr Endocrinol Metab 12:381-387, 1999.
5. Hosoi E, Yokogoshi Y, Horie H, Sano T, Yamada S, Saito S. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by polymerase chain reaction-direct sequencing method using paraffin-embedded tissues. Acta Endocrinol 129:301-306, 1993.
6. Kan B, Esapa C, Sipahi T, Nacar C, Özer F, Sayhan NB. G protein mutations in pituitary tumors: a study on Turkish patients. Pituitary 6:75-80, 2003.
7. Spada A, Arosio M, Bochicchio D, et al. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71:1421-1426, 1990.
8. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761-767, 1999.
9. McCabe CJ, Khaira JS, Boelaert K, et al. Expression of pituitary tumor transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumor behaviour. Clin Endocrinol 58:141-150, 2003.
10. Schmidt MC, Henke RT, Stangl AP, et al. Analysis of the MEN1 gene in sporadic pituitary adenomas. J Pathol 188:168-173, 1999.
11. Tanaka C, Kimura T, Yang P, et al. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the men1 gene on sporadic pituitary adenomas. J Clin Endocrinol Metab 83:2631-2634, 1998.
12. Zhuang Z, Ezzat SZ, Vortmeyer AO, et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57:5446-5451, 1997.
13. Boggild MD, Jenkinson S, Pistorello M, et al. Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab 78:387-392, 1994.
14. Fukino K, Kitamura Y, Sanno N, Teramoto A, Emi M. Analysis of the MEN1 gene in sporadic pituitary adenomas from Japanese patients. Cancer Lett 144:85-92, 1999.
15. Poncin J, Stevenaert A, Beckers A. Somatic MEN1 Gene Mutations does not contribute significantly to sporadic pituitary tumorigenesis. Eur J Endocrinol 140:573-576, 1999.
16. Evans CO, Brown MR, Parks JS, Oyesiku NM. Screening for MEN1 tumor suppressor gene mutations on sporadic pituitary tumors. J Endocrinol Invest 23:304-309, 2000.
17. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91:2815-2821, 1993.
18. Prezant TR, Levine J, Melmed S. Molecular characterizations of the men1 tumor suppressor gene on sporadic pituitary tumors. J Clin Endocrinol Metab 83:1388-1391, 1998.
19. Asa SL, Somers K, Ezzat S. The MEN-1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 83:3210-3212, 1998.
20. Farrell WE, Simpson DJ, Bicknell J, Kyrodimou E, Thakker RV, Clayton RN. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours. Br J Cancer 80:44-50, 1999.
21. kip1 expression in endocrine and other tumors. Am J Pathol 150:401-407, 1997.
22. kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151:509-519, 1997.
23. Kip1 in human pituitary adenomas. Eur J Endocrinol 140:250-255, 1999.
24. kip1 gene and trisomy 12 in a subset of human pituitary adenomas. J Clin Endocrinol Metab 82:3141-3147, 1997.
25. Takeuchi S, Koeffler HP, Hindon DR, Miyishi I, Melmed S, Shimon I. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors. J Endocrinol 157:337-341, 1998.
26. Herwig S, Strauss M. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246:581-601, 1997.
27. Jacks T, Fazeli A, Schimitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 359:295-300, 1992.
28. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee W-H, Lee EY-HP. Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9:1021-1027, 1994.
29. Cryns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 77:644-646, 1993.
30. Woloschak M, Roberts JL, Kalmon D. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer 74:693-696, 1994.
31. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab 78:922-927, 1994.
32. Bates AS, Farrell WE, Bicknell EJ, et al. Allelic deletion in pituitary adenomas reflects aggressive biological and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818-824, 1997.
33. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55:1613-1616, 1995.
34. Hinton DR, Hahn JA, Weiss MH, Couldwell WT. Loss of RB expression in an ACTH-secreting pituitary carcinoma. Cancer Lett 126:209-214, 1998.
35. Simpson DJ, Magnay JM, Bicknell JE, et al. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotropinomas. Cancer Res 59:1562-1566, 1999.
36. Hardy J. Transphenoidal microsurgery treatment of pituitary tumors. In: Linfoot J, ed. Recent advances in the diagnosis and treatment of pituitary tumors. New York: Raven Press, 1979; 375-388.
37. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48:880-888, 1991.
38. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8:1063-1067, 1993.
39. Greger V, Debus N, Lohmann D, Hopping W, Passarge E, Horsthemke B. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 94:491-496, 1994.
40. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG Island. Cancer Res 60:1211-1216, 2000.
41. Ikeda H, Beauchamp RL, Yoshimoto T, Yandell DW. Detection of heterozygous mutation in the retinoblastoma gene in a human pituitary adenoma using PCR-SSCP analysis and direct sequencing. Endocr Pathol 6:189-196, 1995.
42. Daniel DC. Highlight: BRCA1 and BRCA2 proteins in breast cancer. Microsc Res Tech 59:68-83, 2002.
43. Wolf S, Mertens D, Schaffner C, Korz C, Dohner H, Stilgenbauer S. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 10:1275-1285, 2001.
44. Liu Y. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15:2463-2473, 1997.
45. Sossey-Alaoui K, Kitamura E, Head K, Cowell JK. Characterization of FAM10A4, a member of the ST13 tumor suppressor gene family that maps to the 13q14.3 region associated with B-cell leukemia, multiple myeloma, and prostate cancer. Genomics 80:5-7, 2002.
46. Kapanadze B. A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5. FEBS Lett 426:266-270, 1998.
47. Hinoi T, Tani M, Lucas PC, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinoma of the colon. Am J Pathol 159:2239-2248, 2001.
48. Bai YQ, Miyake S, Iwai T, Yuasa Y. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene 22:7942-7949, 2003.
49. Li Y, Pei J, Xia H, Ke H, Wang H, Tao W. Lats2, a putative tumor suppressor, inhibits G1/ S transition. Oncogene 22:4398-4405, 2003.
50. Wieland I, Ropke A, Stumm M, Sell C, Weidle UH, Wieacker PF. Molecular characterization of the DICE1 (DDX26) tumor suppressor gene in lung carcinoma cells. Oncol Res 12:491-500, 2000.
51. Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY. Deleted in liver cancer (DLC)2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem 278:10824-10830, 2003.
52. Chen C, Bhalala HV, Qiao H, Dong JT. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 26:6567-6572, 2002.